tradingkey.logo

Inogen Inc

INGN
5.660USD
0.0000.00%
Cierre 02/06, 16:00ETCotizaciones retrasadas 15 min
153.66MCap. mercado
PérdidaP/E TTM

Más Datos de Inogen Inc Compañía

Inogen, Inc. is a medical technology company offering respiratory products for use in the homecare setting. It supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One and Inogen Rove systems reduce the patient’s reliance on stationary concentrators and scheduled deliveries of tanks with a finite supply of oxygen. Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5, Inogen Rove 4, and Inogen Rove 6, consisting of a front-end mobile application for use by long-term oxygen therapy users. It offers Simeox, which is an airway clearance device.

Información de Inogen Inc

Símbolo de cotizaciónINGN
Nombre de la empresaInogen Inc
Fecha de salida a bolsaFeb 14, 2014
Director ejecutivoSmith (Kevin R. M)
Número de empleados766
Tipo de seguridadOrdinary Share
Fin del año fiscalFeb 14
Dirección859 Ward Drive
CiudadGOLETA
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal93111
Teléfono18055620500
Sitio Webhttps://www.inogen.com/
Símbolo de cotizaciónINGN
Fecha de salida a bolsaFeb 14, 2014
Director ejecutivoSmith (Kevin R. M)

Ejecutivos de Inogen Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Kevin M. King
Mr. Kevin M. King
Independent Director
Independent Director
55.01K
+30612.00%
Mr. Glenn S. Boehnlein, CPA
Mr. Glenn S. Boehnlein, CPA
Independent Director
Independent Director
55.01K
+30612.00%
Mr. Michael J. Bourque
Mr. Michael J. Bourque
Chief Financial Officer, Executive Vice President, Corporate Treasurer
Chief Financial Officer, Executive Vice President, Corporate Treasurer
49.15K
+1500.00%
Mr. Gregoire Ramade
Mr. Gregoire Ramade
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
37.25K
+18623.00%
Ms. Mira Sahney
Ms. Mira Sahney
Independent Director
Independent Director
30.61K
+30612.00%
Ms. Heather D. Rider
Ms. Heather D. Rider
Independent Director
Independent Director
--
--
Ms. Elizabeth (Beth) Mora, CPA
Ms. Elizabeth (Beth) Mora, CPA
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Mary Katherine (Kay) Ladone
Ms. Mary Katherine (Kay) Ladone
Independent Director
Independent Director
--
--
Mr. Ryan Peterson
Mr. Ryan Peterson
Associate Director - Investor Relations
Associate Director - Investor Relations
--
--
Mr. Kevin R. M. Smith
Mr. Kevin R. M. Smith
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Kevin M. King
Mr. Kevin M. King
Independent Director
Independent Director
55.01K
+30612.00%
Mr. Glenn S. Boehnlein, CPA
Mr. Glenn S. Boehnlein, CPA
Independent Director
Independent Director
55.01K
+30612.00%
Mr. Michael J. Bourque
Mr. Michael J. Bourque
Chief Financial Officer, Executive Vice President, Corporate Treasurer
Chief Financial Officer, Executive Vice President, Corporate Treasurer
49.15K
+1500.00%
Mr. Gregoire Ramade
Mr. Gregoire Ramade
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
37.25K
+18623.00%
Ms. Mira Sahney
Ms. Mira Sahney
Independent Director
Independent Director
30.61K
+30612.00%
Ms. Heather D. Rider
Ms. Heather D. Rider
Independent Director
Independent Director
--
--

Desglose de ingresos

Divisa: USDActualizado: mar., 6 de ene
Divisa: USDActualizado: mar., 6 de ene
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
La empresa aún no ha revelado los datos relevantes.
Por regiónUSD
Nombre
Ganancia
Proporción
U.S. revenue
53.99M
58.43%
Non-U.S. revenue
38.40M
41.57%
Por negocio
Por región
La empresa aún no ha revelado los datos relevantes.

Estadísticas de accionistas

Actualizado: lun., 17 de nov
Actualizado: lun., 17 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.- 20211st Phase ESOP
9.67%
BlackRock Institutional Trust Company, N.A.
5.50%
The Vanguard Group, Inc.
5.24%
Acadian Asset Management LLC
3.93%
Camber Capital Management LP
3.59%
Otro
72.07%
Accionistas
Accionistas
Proporción
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.- 20211st Phase ESOP
9.67%
BlackRock Institutional Trust Company, N.A.
5.50%
The Vanguard Group, Inc.
5.24%
Acadian Asset Management LLC
3.93%
Camber Capital Management LP
3.59%
Otro
72.07%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
26.18%
Investment Advisor/Hedge Fund
25.71%
Hedge Fund
17.94%
Corporation
9.67%
Individual Investor
2.48%
Research Firm
1.98%
Family Office
0.89%
Pension Fund
0.26%
Bank and Trust
0.20%
Otro
14.68%

Participación institucional

Actualizado: jue., 1 de ene
Actualizado: jue., 1 de ene
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
302
19.79M
72.88%
-4.43M
2025Q3
308
19.98M
73.65%
-4.59M
2025Q2
330
22.77M
84.68%
-2.73M
2025Q1
372
22.71M
84.47%
-2.93M
2024Q4
375
21.79M
82.19%
-5.25M
2024Q3
367
21.78M
91.28%
-6.90M
2024Q2
360
23.19M
97.91%
-6.59M
2024Q1
364
22.78M
97.44%
-4.92M
2023Q4
369
22.26M
95.31%
-4.56M
2023Q3
386
22.05M
94.85%
-5.76M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.- 20211st Phase ESOP
2.63M
9.67%
+2.63M
--
Feb 21, 2025
BlackRock Institutional Trust Company, N.A.
1.49M
5.5%
-24.35K
-1.61%
Sep 30, 2025
The Vanguard Group, Inc.
1.43M
5.27%
-223.18K
-13.50%
Sep 30, 2025
Acadian Asset Management LLC
1.07M
3.93%
+49.84K
+4.90%
Sep 30, 2025
Camber Capital Management LP
975.00K
3.59%
--
--
Jun 30, 2025
Armistice Capital LLC
864.00K
3.18%
+200.00K
+30.12%
Sep 30, 2025
Columbia Threadneedle Investments (US)
852.73K
3.14%
-28.37K
-3.22%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
832.53K
3.07%
+346.00
+0.04%
Sep 30, 2025
Geode Capital Management, L.L.C.
609.29K
2.24%
-5.99K
-0.97%
Sep 30, 2025
Dafna Capital Management, LLC
605.63K
2.23%
--
--
Sep 30, 2025
Ver más

ETFs relacionados

Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
Cultivar ETF
0.59%
Invesco NASDAQ Future Gen 200 ETF
0.55%
Federated Hermes MDT Small Cap Core ETF
0.25%
JPMorgan Fundamental Data Science Small Core ETF
0.11%
iShares Micro-Cap ETF
0.04%
Avantis US Small Cap Equity ETF
0.02%
Proshares Ultra Russell 2000
0.01%
ProShares Hedge Replication ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Global X Russell 2000 ETF
0.01%
Ver más
Cultivar ETF
Proporción0.59%
Invesco NASDAQ Future Gen 200 ETF
Proporción0.55%
Federated Hermes MDT Small Cap Core ETF
Proporción0.25%
JPMorgan Fundamental Data Science Small Core ETF
Proporción0.11%
iShares Micro-Cap ETF
Proporción0.04%
Avantis US Small Cap Equity ETF
Proporción0.02%
Proshares Ultra Russell 2000
Proporción0.01%
ProShares Hedge Replication ETF
Proporción0.01%
ProShares UltraPro Russell2000
Proporción0.01%
Global X Russell 2000 ETF
Proporción0.01%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
KeyAI